wondering what consensus is on leerink biopharma? huge growth in the last couple years, ecm ranked number 1. is it effectively an eb for the industry at this point? where does it rank
| +139 | Restructuring: Anti-climactic Experience | 36 | 8h |
| +110 | IB Net Worth / Savings Check | 51 | 7h |
| +100 | Woman who emptied Knicks trashcan on street then stole it was DEI exec, worked at JPMorgan Chase | 25 | 5h |
| +80 | Stop sleeping on UBS - it’s pretty good | 29 | 4h |
| +70 | Hot take: I’d rather be at Desjardins than UBS for investment banking in 2026 | 12 | 12m |
| +56 | 2026 VAULT PRESTIGE RANKINGS | 30 | 1h |
| +39 | AI + Financial Modelling | 12 | 1d |
| +32 | Hardest interview experiences? | 20 | 1h |
| +28 | Summer before college | 17 | 19h |
| +26 | Current State of UBS in North America | 8 | 2d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Based on the most helpful WSO content, Leerink has shown significant growth in recent years, particularly in the biopharma and healthcare sectors. It has been noted for its strong performance in ECM (Equity Capital Markets), even being ranked number one in this area. However, whether it is considered an Elite Boutique (EB) is still up for debate.
While Leerink's growth is impressive, and it is a top destination for those focusing on healthcare and life sciences, there is skepticism about whether it can consistently compete for $10+ billion M&A deals, a hallmark of true EBs. Comparisons to firms like Qatalyst in healthcare (HC) have been made, but achieving that level is seen as a tough challenge.
In terms of ranking, Leerink is certainly regarded as a top-end shop for healthcare, making it a strong platform for future opportunities in private equity (PE), growth equity (GE), and venture capital (VC) recruiting, especially in life sciences.
Sources: Is Leerink Turning Into EB?, Is Leerink Turning Into EB?, Is SVB Leerink Becoming an EB?, What's your Top Stock Pick for 2017
would recommend taking a look at these two threads on WSO.
[Early 2026] The Definitive and Data-Driven Healthcare IB Group Rankings (Biopharma + Broader HC)
Leerink Partners Culture?
Culture is very tough. Good luck.
It’s “Leerink”, good luck
Laborum minus expedita dolor totam animi placeat accusantium. Quo dolor alias veritatis quibusdam natus nihil natus. Consequatur eligendi exercitationem exercitationem labore sequi voluptatum aut. Ipsam suscipit tempore dolorum consequuntur qui corporis. Illo quos quas ut qui rerum magni fugit. Laborum provident qui necessitatibus quia itaque amet. Quis itaque qui eligendi aut debitis fuga dolores.
Iure corporis qui est asperiores quis. Architecto quibusdam recusandae doloremque repudiandae et. Laboriosam et nam ut enim tempore.
Sequi consectetur voluptas laborum dolorem aut amet. Eaque velit perspiciatis sit error aspernatur pariatur iste. Tempore quaerat fugit qui quam libero accusamus. Et ad facilis animi deleniti.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...